Molecular tumour boards: The Australian consortium

被引：0
|
作者：
Karroum, Lama [1 ]
Shrestha, Sudi [1 ]
Shackleton, Mark [1 ,2 ,3 ,4 ,5 ]
Southey, Melissa C. [1 ,6 ,7 ]
机构：
[1] Monash Partners Comprehens Canc Consortium, Clayton, Vic, Australia
[2] Monash Univ, Monash Hlth, Sch Clin Sci, Precis Med, Clayton, Vic, Australia
[3] Canc Council Victoria, Canc Epidemiol Div, East Melbourne, Vic, Australia
[4] Monash Univ, Victorian Heart Inst, Clayton, Vic, Australia
[5] Univ Melbourne, Melbourne Med Sch, Dept Clin Pathol, Parkville, Vic, Australia
[6] Monash Univ, Sch Translat Med, Melbourne, Vic, Australia
[7] Alfred Hlth, Dept Oncol, Melbourne, Vic, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
434
引用
收藏
页码：213 / 213
页数：1
相关论文
共 50 条
  • [1] Trust and responsibility in molecular tumour boards
    Merry, David
    Schickhardt, Christoph
    Mehlis, Katja
    Winkler, Eva C.
    BIOETHICS, 2018, 32 (07) : 464 - 472
  • [2] Patient attrition in Molecular Tumour Boards: a systematic review
    Frost, Hannah
    Graham, Donna M.
    Carter, Louise
    O'Regan, Paul
    Landers, Donal
    Freitas, Andre
    BRITISH JOURNAL OF CANCER, 2022, 127 (08) : 1557 - 1564
  • [3] Patient attrition in Molecular Tumour Boards: a systematic review
    Hannah Frost
    Donna M. Graham
    Louise Carter
    Paul O’Regan
    Dónal Landers
    André Freitas
    British Journal of Cancer, 2022, 127 : 1557 - 1564
  • [4] Molecular tumour boards — current and future considerations for precision oncology
    Apostolia M. Tsimberidou
    Michael Kahle
    Henry Hiep Vo
    Mehmet A. Baysal
    Amber Johnson
    Funda Meric-Bernstam
    Nature Reviews Clinical Oncology, 2023, 20 : 843 - 863
  • [5] Molecular tumour boards - current and future considerations for precision oncology
    Tsimberidou, Apostolia M.
    Kahle, Michael
    Vo, Henry Hiep
    Baysal, Mehmet A.
    Johnson, Amber
    Meric-Bernstam, Funda
    NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (12) : 843 - 863
  • [6] Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations
    Annelieke E. C. A. B. Willemsen
    Sarah Krausz
    Marjolijn J. L. Ligtenberg
    Katrien Grünberg
    Harry J. M. Groen
    Emile E. Voest
    Edwin P. J. G. Cuppen
    Hanneke W. M. van Laarhoven
    Carla M. L. van Herpen
    British Journal of Cancer, 2019, 121 : 34 - 36
  • [7] Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations
    Willemsen, Annelieke E. C. A. B.
    Krausz, Sarah
    Ligtenberg, Marjolijn J. L.
    Grunberg, Katrien
    Groen, Harry J. M.
    Voest, Emile E.
    Cuppen, Edwin P. J. G.
    van Laarhoven, Hanneke W. M.
    van Herpen, Carla M. L.
    BRITISH JOURNAL OF CANCER, 2019, 121 (01) : 34 - 36
  • [8] Advancing molecular tumour boards: highly needed to maximise the impact of precision medicine
    van de Haar, Joris
    Hoes, Louisa
    Voest, Emile
    ESMO OPEN, 2019, 4 (02)
  • [9] Tumour boards in geriatric oncology
    Wildes, Tanya Marya
    O'Donovan, Anita
    Colloca, Giuseppe Ferdinando
    Cheung, Kwok-Leung
    AGE AND AGEING, 2018, 47 (02) : 168 - 170
  • [10] A 10th of GPs on consortium boards are also on boards of private firms
    O'Dowd, Adrian
    BRITISH MEDICAL JOURNAL, 2011, 342
12345